HealthSTAT

Growing Alarm Over Rare Disease Drug Linked to Seven Deaths and Nearly 100 Hospitalizations

Patient advocates and experts are raising concerns about Vykat XR, a Neurocrine Biosciences drug for Prader-Willi syndrome. Since its approval 18 months ago, it has been linked to seven deaths and nearly 100 hospitalizations.